Twelve years ago, breast oncologist Dr. Marisa Weiss and her mother, Ellen Weiss, wrote the indispensable and highly acclaimed survivors' guide, Living Beyond Breast Cancer. A decade later, they embarked on a two-year long research effort to completely update this resource - now titled Living Well Beyond Breast Cancer: A Survivor's Guide to When Treatment Ends and the Rest of Your Life Begins. The new title celebrates advancements in breast cancer treatment and recognizes the need to both live well and live well beyond the disease.
The need to incorporate major new advances in breast cancer treatment and recovery was one major reason to update the book. Another key factor was the desire to share the authors' own personal journey with breast cancer. Ellen Weiss was diagnosed with breast cancer five years ago - an event that altered the perspective of both authors, giving them a different, very personal lens into the daily physical and emotional challenges survivors face after the initial crisis of breast cancer is over.
"I've been treating breast cancer patients for over 20 years," says Dr. Weiss. "However, my mother's own diagnosis made me appreciate in a much more personal way the fears that breast cancer patients and their families experience along the way - and deepened my commitment to my life's work."
Central to Dr. Weiss' commitment is her nonprofit organization, Breastcancer.org, which provides vital, reliable information and support to those affected by breast cancer. Today, Breastcancer.org reaches over eight million people each year across the world with expert-reviewed information and peer support.
Written to complement the tremendous resource of Breastcancer.org, Living Well Beyond Breast Cancer covers a wide range of issues: managing chemo-brain, getting a good night's sleep, cooling hot flashes, keeping your bones strong, controlling your weight, tolerating ongoing treatments, knowing which tests to get, and reducing the risk of recurrence. Visit Breastcancer.org to learn more about Living Well Beyond Breast Cancer.
New trials show promise for immune checkpoint blockers in early-stage lung cancer